Physician profile
Aaron Bond
NPI 1104115385
$4,795.70
in general payments reported to CMS, 2019-2025
22 companies · $150 in 2025
The $150 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $791 · 2020: $425 · 2021: $2,831 · 2022: $266 · 2023: $234 · 2024: $100 · 2025: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $484.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $483.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,927.53 | 2021-2023 | Intellis Adaptivestim, Activa Pc |
| Insightec,INC | $355.82 | 2020 | |
| Stryker Corporation | $267.46 | 2019 | |
| Medicrea USA, Corp. | $196.32 | 2019 | |
| Abbott Laboratories | $180.95 | 2021-2023 | Infinity |
| Gt Medical Technologies, INC | $149.64 | 2025 | Gammatile |
| Livanova USA, INC. | $143.97 | 2019-2021 | |
| Integra Lifesciences Corporation | $125.00 | 2019 | |
| Boston Scientific Corporation | $72.91 | 2022-2023 | |
| Medtronic USA, INC. | $70.73 | 2019-2020 | |
| Orthofix Medical, INC. | $62.31 | 2019-2020 | |
| Si-Bone, INC. | $38.37 | 2022-2024 | |
| Bioventus LLC | $34.09 | 2024 | Bonescalpel & Sonicone (O.R.) |
| Portola Pharmaceuticals, LLC | $25.73 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $25.43 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $23.92 | 2024 | Nuplazid |
| Depuy Synthes Sales INC. | $19.75 | 2020 | |
| Baxter Healthcare | $19.72 | 2024 | Floseal |
| Avanir Pharmaceuticals, INC. | $16.22 | 2019 | |
| Zyla Life Sciences, INC. | $15.12 | 2020 | |
| Globus Medical, INC. | $12.99 | 2021 | |
| Amneal Pharmaceuticals LLC | $11.72 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Bond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.